Trial intelligence / Profile preview

EXAMI: Exenatide as additional treatment in acute myocardial infarction

2009-014272-21Phase 2Active

Sponsor
VU University Medical Center
Start
Jul 2009
Modality
Peptides
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in myocardial infarction (MI) comparing Exenatide + primary PCI with Placebo + primary PCI (2 arms). Started Jul 2009; status: active.

02

Drugs

exenatide
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2009-014272-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014272-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call